Skip to main content
. 2014 Jan 6;111(1-2):3–9. doi: 10.3238/arztebl.2014.0003

Figure 1.

Figure 1

Overall survival after 30 years in Hodgkin’s disease treatment trials HD-78 to HD-90 in boys and girls (as of 1 July 2012).

*1 Causes of death in female patients: Hodgkin’s disease (n = 18),

post-splenectomy sepsis (n = 7), secondary malignancy (n = 15, 3 of them breast cancer), heart disease (n = 6), other (n = 10, including accidents and suicide)

*2 With documentation of disease course

SE, standard error